PT  - JOURNAL ARTICLE
AU  - Ahmed, Ali
TI  - Does COVID-19 Testing Create More Cases? An Empirical Evidence on the Importance of Mass Testing During a Pandemic
AID  - 10.1101/2020.12.23.20248740
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.12.23.20248740
4099  - http://medrxiv.org/content/early/2020/12/26/2020.12.23.20248740.short
4100  - http://medrxiv.org/content/early/2020/12/26/2020.12.23.20248740.full
AB  - The importance of testing and surveillance of an infectious disease cannot be underestimated. The testing is the first step to detect an infectious disease, and mass testing can slow or mitigate the spread of an infectious disease. Despite overwhelming evidence and the importance of testing discussed in the literature, there have been claims that “more COVID-19 testing creates more cases”. Therefore, there is a need to study whether massive testing is the reason for detecting more positive COVID-19 cases. In this research, we used a dataset from the U.S. Department of Health & Human Services and empirically showed that by increasing the COVID-19 testing in the U.S., the spread of the COVID-19 decreased significantly. Our results indicate a negative relationship between the number of positive cases and the number of tests performed in the past months. The large-scale testing may have helped identify positive and asymptomatic cases early in the course of illness, which enabled individuals to isolate themselves, thus reducing the chances of spreading the diseases and slowing the spread of the pandemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB Exempt.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDepartment of Health & Human Services. COVID-19 Diagnostic Laboratory Testing (PCR Testing) Time Series. https://healthdata.gov/dataset/covid-19-diagnostic-laboratory-testing-pcr-testing-time-series. Published 2020. https://healthdata.gov/dataset/covid-19-diagnostic-laboratory-testing-pcr-testing-time-series